June 25, 2008
The United States Anti-Doping Agency (USADA) announced today that Ryanne DuPree, of San Antonio, TX, an athlete in the sport of Track & Field, tested positive for a prohibited substance and accepted a public warning for her first doping offense. The doping offense involved the use of a prescribed medication under the care of a physician but without first seeking a therapeutic use exemption as required by the applicable rules.
DuPree tested positive for salbutamol, a beta-2 agonist, on March 9, 2008, at the USA Indoor Combined Events in Chapel Hill, NC. Salbutamol is prohibited under the rules of the International Association of Athletics Federations (IAAF) and USADA, both of which adopted the World Anti- Doping Code and the World Anti-Doping Agency’s (WADA) Prohibited List. Although salbutamol is a prohibited substance under the applicable rules, an athlete who provides documentation in advance of competition, confirming the diagnosis of a valid medical need, may receive an exemption allowing the use of the substance. DuPree did not have an exemption to use salbutamol.
As a result of the doping violation, DuPree, 24, has been disqualified from the 2008 USA Indoor Combined Events in Chapel Hill, NC, including her third-place finish in the pentathlon.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.